Effects of an Opioid Sparing Care Pathway for Patients undergoing Obesity Surgery
Phase 1
Recruiting
- Conditions
- Pain, postoperative, ObesityTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
- Registration Number
- CTIS2023-505934-86-00
- Lead Sponsor
- Vaestra Goetalandsregionen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 220
Inclusion Criteria
Patients =18 years planned to undergo laparoscopic obesity surgery (GBP alt Sleeve surgery) at the selected site.
Exclusion Criteria
ASA> III, Patients treated with opioids for chronic pain, Substance abuse, Hypersensitivity to Oxycodone, Esketamine, Dexmedetomidine, and Lidocaine, Pacemaker or ICD, Inability to fill in questionnaires, Decline participation, Cardiovascular disease with bradycardia (<50 bpm), Serious liver disease failure, Insufficient knowledge of the Swedish language, Serious untreated psychiatric disease, Neurocognitive dysfunction, Pregnancy, Women of childbearing age without contraception, Malignant disease with expected short survival
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method